Sanofi SA at Leerink Partners Global Biopharma Conference Transcript
All right. Good morning, everyone. So my name is Dave Risinger. I cover diversified biopharmaceuticals for Leerink Partners, and it's very much my pleasure to welcome you to this session with Sanofi. And I am pleased that we're able to be joined by the 2 key leaders of the Immunology franchise at the company. So Shaju Backer to my immediate left, is the Global Head of the Immunology franchise; Naimish Patel is the Global Head of Development for Immunology and Inflammation. And so thank you both for being with us today.
Questions & Answers
And it's actually great timing on the heels of AAD. And so I thought maybe you could start with just some comments on the momentum for the company and quick takeaways from AAD.
Sure. So Naimish, I might talk
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
